Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Poppi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Proteomics|August 3, 2023
Preomic profile of BxPC-3 cells after treatment with BRC4Viola Previtali, Samuel H Myers, Laura Poppi, et al.
International Journal of Molecular Sciences|August 12, 2022
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous RecombinationFabrizio Schipani, Marcella Manerba, Roberto Marotta, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid SeriesGiovanni Ferrandi, Greta Bagnolini, Laura Poppi, et al.
Critical Reviews in Oncology/Hematology|June 7, 2025
Exploring the role of TERT in thyroid Cancer: A systematic reviewThais Maloberti, Andrea Repaci, Laura Poppi, et al.
European Thyroid Journal|November 1, 2025
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cellsGiulia Calafato, Floriana Jessica Di Paola, Antonio De Leo, et al.
European Journal of Medicinal Chemistry|January 9, 2024
An <sup>19</sup>F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancerSamuel H Myers, Laura Poppi, Francesco Rinaldi, et al.
The Journal of Liquid Biopsy|October 27, 2025
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral centerThais Maloberti, Laura Poppi, Giulia Ciccimara, et al.
Histopathology|August 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtypeMarco Grillini, Jacopo Lenzi, Claudio Ceccarelli, et al.
Cell Death Discovery|March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activityMirco Masi, Laura Poppi, Viola Previtali, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Proteomics|August 3, 2023
Preomic profile of BxPC-3 cells after treatment with BRC4Viola Previtali, Samuel H Myers, Laura Poppi, et al.
International Journal of Molecular Sciences|August 12, 2022
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous RecombinationFabrizio Schipani, Marcella Manerba, Roberto Marotta, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid SeriesGiovanni Ferrandi, Greta Bagnolini, Laura Poppi, et al.
Critical Reviews in Oncology/Hematology|June 7, 2025
Exploring the role of TERT in thyroid Cancer: A systematic reviewThais Maloberti, Andrea Repaci, Laura Poppi, et al.
European Thyroid Journal|November 1, 2025
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cellsGiulia Calafato, Floriana Jessica Di Paola, Antonio De Leo, et al.
European Journal of Medicinal Chemistry|January 9, 2024
An <sup>19</sup>F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancerSamuel H Myers, Laura Poppi, Francesco Rinaldi, et al.
The Journal of Liquid Biopsy|October 27, 2025
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral centerThais Maloberti, Laura Poppi, Giulia Ciccimara, et al.
Histopathology|August 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtypeMarco Grillini, Jacopo Lenzi, Claudio Ceccarelli, et al.
Cell Death Discovery|March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activityMirco Masi, Laura Poppi, Viola Previtali, et al.
Pageof 1